Docusign shares rose 2.33% to $73.99 at the time of publication on Wednesday, despite a broader technology sector decline. The stock was trading near its 52-week high of $75, according to Benzinga Pro data. The rally appears to reflect continued buying interest following a strong recovery over recent months.
Docusign announced an expanded partnership with Salesforce on Tuesday to integrate Docusign's Intelligent Agreement Management platform into Salesforce, Agentforce and Slack. The integration allows sales teams to generate contracts, track renewals, review agreements and manage approvals without switching applications. The integration also enables Salesforce's AI agents to access contract information, identify potential risks and automate agreement workflows. The expansion builds on a partnership of more than 20 years and expands Docusign's role in AI-powered business automation.
Docusign is trading above its key moving averages, signaling a strong upward trend. The stock sits 6.8% above its 20-day simple moving average of $69.40. The stock sits 38% above its 200-day simple moving average of $53.72. The 20-day simple moving average remains above the 50-day simple moving average. The 50-day simple moving average moved above the 200-day simple moving average in August, forming a golden cross.
The moving average convergence divergence indicator remains above its signal line. A positive histogram further suggests that buying momentum is strengthening. However, the stock is approaching a key resistance zone near its 52-week high. Traders are watching resistance at $74.50, followed by the $75 high. A sustained move above these levels could support further gains. The stock has a key support level at $63.50.
Docusign trades at a price-to-earnings ratio of 44.1, reflecting a premium valuation. Analysts maintain a consensus Hold rating, with an average price forecast of $68.92. Piper Sandler raised its price forecast to $75 on September 4 and maintained a Neutral rating. Citigroup increased its price forecast to $72 and maintained a Neutral rating. Morgan Stanley raised its price forecast to $75 and maintained an Equal-Weight rating.
Benzinga Edge Rankings give Docusign a Momentum score of 92.01 out of 100. Benzinga Edge Rankings give Docusign a Growth score of 83.82. However, Benzinga Edge Rankings give Docusign a Value score of 43.9. These readings suggest that momentum and growth expectations are supporting investor interest, while valuation remains a potential concern.
VictoryShares Small Cap Free Cash Flow ETF (SFLO) holds Docusign at a 1.67% portfolio weighting. Aztlan Global Stock Selection DM SMID ETF (AZTD) holds Docusign at a 2.89% portfolio weighting. First Trust SMID Growth Strength ETF (FSGS) holds Docusign at a 1.31% portfolio weighting. Changes in these funds' holdings or investor flows could influence demand for Docusign shares.
DocuSign Stock Rises on Expanded Salesforce Partnership
BenzingaShare
Summary
DocuSign (NASDAQ: DOCU) shares climbed 2.33% to $73.99 on Wednesday, nearing its 52-week high of $75. The stock gained after a partnership announcement with Salesforce to integrate DocuSign’s Intelligent Agreement Management platform into Salesforce, Agentforce, and Slack. The move allows sales teams to handle contracts and approvals within existing apps. Salesforce’s AI agents can now access contract data and automate workflows. The partnership announcement has been labeled as on-chain news by some analysts.
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.